Correlation Between Bone Biologics and NuVasive
Can any of the company-specific risk be diversified away by investing in both Bone Biologics and NuVasive at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bone Biologics and NuVasive into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bone Biologics Corp and NuVasive, you can compare the effects of market volatilities on Bone Biologics and NuVasive and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bone Biologics with a short position of NuVasive. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bone Biologics and NuVasive.
Diversification Opportunities for Bone Biologics and NuVasive
-0.51 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Bone and NuVasive is -0.51. Overlapping area represents the amount of risk that can be diversified away by holding Bone Biologics Corp and NuVasive in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NuVasive and Bone Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bone Biologics Corp are associated (or correlated) with NuVasive. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NuVasive has no effect on the direction of Bone Biologics i.e., Bone Biologics and NuVasive go up and down completely randomly.
Pair Corralation between Bone Biologics and NuVasive
Given the investment horizon of 90 days Bone Biologics Corp is expected to under-perform the NuVasive. In addition to that, Bone Biologics is 5.98 times more volatile than NuVasive. It trades about -0.03 of its total potential returns per unit of risk. NuVasive is currently generating about 0.02 per unit of volatility. If you would invest 4,141 in NuVasive on August 30, 2024 and sell it today you would earn a total of 94.00 from holding NuVasive or generate 2.27% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 31.25% |
| Values | Daily Returns |
Bone Biologics Corp vs. NuVasive
Performance |
| Timeline |
| Bone Biologics Corp |
| NuVasive |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Bone Biologics and NuVasive Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Bone Biologics and NuVasive
The main advantage of trading using opposite Bone Biologics and NuVasive positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bone Biologics position performs unexpectedly, NuVasive can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NuVasive will offset losses from the drop in NuVasive's long position.| Bone Biologics vs. Edwards Lifesciences Corp | Bone Biologics vs. Outset Medical | Bone Biologics vs. Venus Concept | Bone Biologics vs. DexCom Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |